Nuvalent, Inc. (NUVL)

NASDAQ

$--

(--)

Regular Market

Nuvalent, Inc. (NUVL) Live Price Chart

Last updated: ⁦2026-10-21 18:37:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Nuvalent, Inc. (NUVL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Nuvalent, Inc. (NUVL) Stock Price Today

Nuvalent, Inc. (NUVL) is currently trading at $-- as of --, -- from the previous close of $--

During today's regular trading session, NUVL has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.

Nuvalent, Inc. (NUVL) 7-Day Stock Price Change

Over the past seven days, Nuvalent, Inc. (NUVL) moved from $123.70 to $123.96, representing a gain of 0.21% ($0.26).

The stock traded between $123.55 and $123.99 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 1.92 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Nuvalent, Inc. (NUVL)?

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Nuvalent, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	228
Exchange	NASDAQ
Company Website	https://www.nuvalent.com

How to Buy Nuvalent, Inc. (NUVL) Stock on MEXC

Eligible investors can buy real shares of Nuvalent, Inc. (NUVL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NUVL and Place Your Order

Open the RealStocks trading page and search for NUVL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nuvalent, Inc. (NUVL) stock price today?

Nuvalent, Inc. (NUVL) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is NUVL stock going up or down today?

As of --, NUVL is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is NUVL pre-market price?

As of --, NUVL is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NUVL after-hours price?

As of --, NUVL is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NUVL stock trading now?

NUVL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NUVL sit relative to its 52-week high and low?

Over the past 52 weeks, NUVL has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nuvalent, Inc. in?

Nuvalent, Inc. (NUVL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nuvalent, Inc.'s market capitalization and where is it listed?

Nuvalent, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NUVL valued in terms of P/E ratio and EPS?

NUVL trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nuvalent, Inc. pay a dividend?

Nuvalent, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.